ERDAFITINIB vs IBRUTINIB

I have shared some details of my mom's experiences on erdafitinib in a clinical trial and wanted to share an amazing update -- she had about a 30% reduction in her tumor today (the image on the left) compared to February (the image on the right). This comes after another 20% reduction she had in ear

TLDR; summary of my BC experience through surgeries, gem/cis, Keytruda/Padcev, radiation, neuropathy that caused me to drop the therapy (cancer was stable), and potential next steps. Today I (43m) had my last dose of Keytruda. Back in April I had my last dose of Padcev. I see people here asking abou

Hi all! A few months back I posted about my mom (68) being put in a clinical trial with erdafitinib after her glioblastoma continued to progress following radiation and chemo after her brain surgery in February of this year. She was a candidate for this trial because of a fairly rare FGFR fusion her

US pharmer here. Hoping for assistance from any pharmacists that work in Canada. Have a patient with pancreatic cancer, oncology has recommended starting of Balversa (erdafitinib). Insurance of course is saying this is a no-go, as it is not currently FDA approved for pancreatic cancer. They are now

Hi all. My mom has recently been enrolled in a clinical trial testing the effectiveness of erdafitinib based off a fairly rare FGFR fusion her tumor has (about 3% of all cases of glioblastoma). She has just started taking the medication within the last week. This is after a 95%+ resection of her tum

Hey everyone, get ready for some deep due diligence, this time not for REGAL, but for SLS-009, buyout, and what the future will look like with buyout from a strategic acquirer. Before I start, I would suggest for those haven’t yet, read Part 1 and Part 2 that goes over the deep due diligence and mac

Hey everyone, get ready for some deep due diligence, this time not for REGAL, but for SLS-009, buyout, and what the future will look like with buyout from a strategic acquirer. Before I start, I would suggest for those haven’t yet, read Part 1 and Part 2 that goes over the deep due diligence and mac

Hi everyone. I’m looking for insight from others with CLL experience. My dad has CLL with 96% involvement in his bone marrow per recent biopsy. His platelets are low, and over the past two weeks his anemia has worsened very very quickly. Recent timeline: Hospitalized with hemoglobin \~7.5 and fever

To Those Who Wish to learn, I feel like I may be giving away a secret.... but... here it goes... Earlier today I had a [twitter conversation](https://twitter.com/sentivcapital/status/1663230898702106634) about AI in regards to potential for future impact on stocks. I received a lot of DMs and to be

I’ve been pretty successful in a media career but now, at 43, 3 years post my diagnosis with my cancer under control (no cure... a rare lymphoma/on ibrutinib forever) two kids 7 and 4 at home and the sole breadwinner for the family, I’m so disenchanted. I finally feel great health wise... back to m

I was researching to find out * Examples of cancer drugs in the past that came to market later where treatments already existed, but ended up being commercially successful - * What were the characteristics of these late entrants that led to their success and does Cosibelimab have some of these char

**Is progression a meaningful outcome measure for a patient with indolent lymphoma** **If I don't feel anything (i.e. asymptomatic) and can live for decades with my lymphoma should I even worry about the fact that I have some enlarged lymph nodes or abnormalities of my lab work ???** I had a dis

Apparently a patient had been administering the medication this way... It's on the ISMP do not crush list. I called the manufacturer (Pharmacyclics) and they had no data on administering through any enteral feeding tubes, so they recommended not to give the medication in this manner. I can't find an